24 May 2013
Keywords: sumitomo, licensing, novirio, hep, drug, pharmaceuticals, based
Article | 03 July 2001
Sumitomo Pharmaceuticals, based in Osaka, Japan, has signed a licensingagreement with Novirio of the USA, with reference to the latter's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 June 2001
23 May 2013
© 2013 thepharmaletter.com